Danish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

chemotherapy/hypoxia

Linket gemmes på udklipsholderen
9 resultater

Modified bacteria and their uses thereof for the treatment of cancer or tumor

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Apr. 30, 2013, is named Sequence_Listing.sub.--002893-US1.txt and is 10,182 bytes in size. 1.

Substituted 5-membered ring compounds and their use

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
This application is a U.S. National Stage application of co-pending PCT application PCT/GB2004/002755, filed Jun. 24, 2004, which claims the priority of Great Britain Patent Application No. 0315111.5, filed Jun. 27, 2003. These applications are incorporated herein by reference in their

Use of an agent that restores tissue perfusion and oxygenation

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD The presently disclosed subject matter provides methods for increasing perfusion in hypoxic regions of tissues in subjects. Also provided are methods for treating diseases and/or disorders associated with hypoxia in subjects, methods for increasing sensitivity of tumors to radiation

Use of an agent that restores tissue perfusion and oxygenation

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD The presently disclosed subject matter provides methods for increasing perfusion in hypoxic regions of tissues in subjects. Also provided are methods for treating diseases and/or disorders associated with hypoxia in subjects, methods for increasing sensitivity of tumors to radiation

Use of an agent that restores tissue perfusion and oxygenation

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD The presently disclosed subject matter provides methods for increasing perfusion in hypoxic regions of tissues in subjects. Also provided are methods for treating diseases and/or disorders associated with hypoxia in subjects, methods for increasing sensitivity of tumors to radiation

Use of an agent that restores tissue perfusion and oxygenation

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD The presently disclosed subject matter provides methods for increasing perfusion in hypoxic regions of tissues in subjects. Also provided are methods for treating diseases and/or disorders associated with hypoxia in subjects, methods for increasing sensitivity of tumors to radiation

Use of an agent that restores tissue perfusion and oxygenation

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD The presently disclosed subject matter provides methods for increasing perfusion in hypoxic regions of tissues in subjects. Also provided are methods for treating diseases and/or disorders associated with hypoxia in subjects, methods for increasing sensitivity of tumors to radiation

Use of an agent that restores tissue perfusion and oxygenation

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD The presently disclosed subject matter provides methods for increasing perfusion in hypoxic regions of tissues in subjects. Also provided are methods for treating diseases and/or disorders associated with hypoxia in subjects, methods for increasing sensitivity of tumors to radiation

Inhibition of HIF-1 activation for anti-tumor and anti-inflammatory responses

Kun registrerede brugere kan oversætte artikler
Log ind / Tilmeld
TECHNICAL FIELD The presently disclosed subject matter generally relates to methods and compositions for inhibiting the expression and/or activation of hypoxia-inducible factor 1 (HIF-1) gene products in a hypoxic cell. More particularly, the presently disclosed subject matter provides methods and
Deltag i vores
facebook-side

Den mest komplette database med medicinske urter understøttet af videnskab

  • Arbejder på 55 sprog
  • Urtekurer, der understøttes af videnskab
  • Urtegenkendelse ved billede
  • Interaktivt GPS-kort - tag urter på stedet (kommer snart)
  • Læs videnskabelige publikationer relateret til din søgning
  • Søg medicinske urter efter deres virkninger
  • Organiser dine interesser og hold dig opdateret med nyhedsundersøgelser, kliniske forsøg og patenter

Skriv et symptom eller en sygdom, og læs om urter, der kan hjælpe, skriv en urt og se sygdomme og symptomer, den bruges mod.
* Al information er baseret på offentliggjort videnskabelig forskning

Google Play badgeApp Store badge